HD-OPM Archive
Topics › Aging & longevity

Senolytic dasatinib plus quercetin caused brain damage in mice, urging caution on dosing

Louis Nervegna · Apr 29, 2026 · ♥ 6 reactions · 7 comments · original Facebook post
Aging & longevityBrain health & dementia
AI summary & key facts

Louis shares a study reporting D+Q caused damage in certain brain regions in mice, similar to multiple sclerosis, calling for careful human dosing.

I posted about this study before back in March: ↪ Senolytic dasatinib plus quercetin caused brain demyelination in a 2026 PNAS study.

These senolytic drugs are promising, but getting the dose right in humans is going to be tricky. Too much may cause harm.

#senolyticsHD #agingHD #longevityHD #senescenceHD

Research cited

A new study calls for caution in using the well-known senolytic treatment of dasatinib and quercetin (D+Q), showing that it causes damage in certain regions of the brain, similar to what is observed in multiple sclerosis.

Lifespan Research Institute | Building a Future Free of Age-Related DiseaseA Popular Senolytic Treatment Causes Brain Damage in MiceA new study calls for caution in using the well-known senolytic treatment of dasatinib and quercetin (D+Q), showing that it causes damage in the brain.lifespan.io

By: Anna Barkovskaya

← newer: GLP-1 doses that are too high can mute food noise and pleasuolder: Statins also thicken the fibrous cap of plaques, shown by OC →